Latest Insider Transactions at National Healthcare Corp (NHC)
This section provides a real-time view of insider transactions for National Healthcare Corp (NHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTHCARE CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTHCARE CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
13,109
-64.62%
|
$1,022,502
$78.99 P/Share
|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+44.1%
|
$960,000
$60.73 P/Share
|
Mar 15
2021
|
Emil E Hassan Director |
SELL
Open market or private sale
|
Direct |
1,913
-2.92%
|
$151,127
$79.0 P/Share
|
Mar 02
2021
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+6.91%
|
$123,220
$61.9 P/Share
|
Mar 02
2021
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,750
+0.64%
|
$198,000
$72.94 P/Share
|
Feb 24
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
421
+20.73%
|
-
|
Feb 24
2021
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
633
+37.52%
|
-
|
Feb 24
2021
|
Brian F Kidd SVP, Controller, PAO |
BUY
Grant, award, or other acquisition
|
Direct |
626
+3.52%
|
-
|
Feb 24
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
510
+10.64%
|
-
|
Feb 24
2021
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+3.15%
|
-
|
Feb 24
2021
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
739
+18.45%
|
-
|
Feb 24
2021
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
742
+13.77%
|
-
|
Feb 24
2021
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+1.05%
|
-
|
Jan 06
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
6,905
-64.65%
|
$504,065
$73.97 P/Share
|
Jan 06
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+42.83%
|
$480,000
$60.73 P/Share
|
Jan 01
2021
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
414
-0.84%
|
$27,324
$66.41 P/Share
|
Jan 01
2021
|
Jeffrey Russell Smith SVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-6.44%
|
$11,484
$66.41 P/Share
|
Jan 01
2021
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-9.85%
|
$3,036
$66.41 P/Share
|
Jan 01
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-4.35%
|
$8,052
$66.41 P/Share
|
Jan 01
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-2.32%
|
$1,716
$66.41 P/Share
|
Dec 21
2020
|
Robert Michael Ussery President & COO |
SELL
Bona fide gift
|
Direct |
900
-0.31%
|
-
|
Nov 10
2020
|
Ernest G Burgess Iii Director |
SELL
Open market or private sale
|
Direct |
1,990
-1.09%
|
$141,290
$71.5 P/Share
|
Nov 09
2020
|
Ernest G Burgess Iii Director |
SELL
Open market or private sale
|
Direct |
2,010
-0.72%
|
$140,700
$70.75 P/Share
|